Replies to post #232516 on Biotech Values

[miljenko]

The new data show that a single injection of AB-729 @60mg worked as well as a single injection of AB-729 @180mg in generating a ~1.0-log reduction in HBsAg relative to baseline at 12 weeks.

That 1 log reduction is misleading, *forced* by single subject!
Still, how to explain 180 mg dose failure IF 60 mg is so-so?